Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2025-12-25 @ 9:34 PM
Study NCT ID:
NCT02404051
Status:
UNKNOWN
Last Update Posted:
2016-06-15
First Post:
2015-01-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast Cancer
Sponsor:
Consorzio Oncotech
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-12
Start Date Type:
None
Primary Completion Date:
2018-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2019-01
Completion Date Type:
ESTIMATED
First Submit Date:
2015-01-26
First Submit QC Date:
None
Study First Post Date:
2015-03-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-06-14
Last Update Post Date:
2016-06-15
Last Update Post Date Type:
ESTIMATED